RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Perrigo Company - Stock

Perrigo Company Net Income 2024

Perrigo Company Net Income

301.73 M USD

Perrigo Company Dividend yield

4.04 %

Ticker

PRGO

ISIN

IE00BGH1M568

WKN

A1XAEY

In 2024, Perrigo Company's profit amounted to 301.73 M USD, a -2,475.83% increase from the -12.7 M USD profit recorded in the previous year.

The Perrigo Company Net Income history

YEARNET INCOME (undefined USD)
2028e681.33
2027e556.19
2026e460.71
2025e403.58
2024e301.73
2023-12.7
2022-140.6
2021-68.9
2020-162.6
2019146.1
2018131
2017119.6
2016-4,012.8
2015128
2014205.3
2013441.9
2012401.6
2011339.2
2010223.8
2009145.5
2008134.3
200770.3
200671.4
2005-353
200480.6

Perrigo Company Aktienanalyse

What does Perrigo Company do?

The Perrigo Company PLC is a globally operating company in the pharmaceutical and healthcare products sector. The company was founded in 1887 as The Donerail Corporation and is headquartered in Dublin, Ireland. Perrigo's business model focuses on healthcare products and offers a wide range of products, ranging from over-the-counter medications to dietary supplements and personal care products. The company is divided into three business segments: Consumer Healthcare Americas, serving the markets in North, Central, and South America; Consumer Healthcare International, serving the markets in Europe, Australasia, Asia, and Israel; and Pharmaceutical, which includes pharmaceutical manufacturing and development. The Consumer Healthcare Americas segment focuses on developing products that aid in the treatment and prevention of various health issues. Some of the well-known products include the dietary supplement brand Emergen-C, the allergy and sinus product brand GoodSense, and the pain relief brand TopCare. Consumer Healthcare International offers similar products to the Consumer Healthcare Americas segment, but with a focus on the international market. The product range includes pain relief, cold and flu products, skincare products, vitamins and minerals, oral care products, and household products. The Pharmaceutical segment specializes in the manufacturing and development of generic drugs, biosimilars, and over-the-counter medications. The company has extensive experience in generics manufacturing and has recently expanded its product portfolio to include biologics and pharmaceutical development. Perrigo's pharmaceutical products are widely recognized and sold in many countries. Some of the well-known products include the blockbuster injectable methotrexate Heumann, a highly effective immunosuppressant used in the treatment of autoimmune diseases. Perrigo is a leading provider of quality products and continuously develops new products to meet the needs of its customers. The company places a high value on research and development and works closely with professionals in the medical field. Perrigo has established an extensive global distribution network to ensure its products are available worldwide. In recent years, the company has strengthened its market presence through mergers and acquisitions. In 2015, Perrigo acquired Irish pharmaceutical company Elan Corporation, which specializes in the development of drugs for neurodegenerative diseases. This acquisition expanded Perrigo's product portfolio in biologics development. Since 2019, Ranir, a global leader in oral care products, has also been integrated into the company. In the recent past, Perrigo has set a target date by which it aims to resolve tax issues related to a series of disputed transactions with the IRS. The target is the end of June 2021, by which the company aims to achieve a satisfactory outcome and move forward. Overall, Perrigo has a successful history as a leading provider of pharmaceutical and healthcare products. The company is able to meet the needs of its customers worldwide by offering a wide range of products, from over-the-counter medications to dietary supplements and personal care products. With a strong focus on research and development, Perrigo has strengthened its market presence through mergers and acquisitions in recent years, promising a bright future for the company. Perrigo Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Perrigo Company's Profit Margins

The profit margins of Perrigo Company represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Perrigo Company's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Perrigo Company's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Perrigo Company's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Perrigo Company’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Perrigo Company Stock

How much profit has Perrigo Company made this year?

Perrigo Company has made 301.73 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -2,475.83% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Perrigo Company publish its earnings?

Perrigo Company publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Perrigo Company?

The profits of Perrigo Company are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Perrigo Company?

You can learn more about the earnings of Perrigo Company by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Perrigo Company pay?

Over the past 12 months, Perrigo Company paid a dividend of 1.09 USD . This corresponds to a dividend yield of about 4.04 %. For the coming 12 months, Perrigo Company is expected to pay a dividend of 1.08 USD.

What is the dividend yield of Perrigo Company?

The current dividend yield of Perrigo Company is 4.04 %.

When does Perrigo Company pay dividends?

Perrigo Company pays a quarterly dividend. This is distributed in the months of September, December, April, June.

How secure is the dividend of Perrigo Company?

Perrigo Company paid dividends every year for the past 25 years.

What is the dividend of Perrigo Company?

For the upcoming 12 months, dividends amounting to 1.08 USD are expected. This corresponds to a dividend yield of 4.02 %.

In which sector is Perrigo Company located?

Perrigo Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Perrigo Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Perrigo Company from 6/18/2024 amounting to 0.276 USD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Perrigo Company pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Perrigo Company in the year 2023?

In the year 2023, Perrigo Company distributed 1.04 USD as dividends.

In which currency does Perrigo Company pay out the dividend?

The dividends of Perrigo Company are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Perrigo Company

Our stock analysis for Perrigo Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Perrigo Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.